Extract

The primary objective of the study is to characterize the pharmacokinetics of 10 and 20 mg of rivaroxaban administered as an oral suspension in comparison to a 10 mg immediate release tablet. The potential for a food effect will be investigated for the 20 mg oral suspension

Inclusion criteria

• healthy volunteers (Prevention and teatment of thromboembolic disorders)

Links

• ictrp
• euctr